Second Sight Medical Products
GPTKB entity
Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
medical device
|
| gptkbp:Argus_II_FDA_approval_year |
2013
|
| gptkbp:Argus_II_indication |
retinitis pigmentosa
|
| gptkbp:focusesOn |
visual prosthetics
|
| gptkbp:founded |
1998
|
| gptkbp:founder |
gptkb:Alfred_E._Mann
gptkb:Robert_Greenberg gptkb:Sam_Williams gptkb:Aaron_Mendelsohn |
| gptkbp:headquarters_location |
gptkb:Sylmar,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Second Sight Medical Products
|
| gptkbp:industry |
medical devices
|
| gptkbp:listedOn |
gptkb:NASDAQ
|
| gptkbp:mergedInto |
gptkb:Nano_Precision_Medical
2022 |
| gptkbp:mission |
to develop, manufacture and market implantable visual prosthetics to provide useful vision to blind individuals
|
| gptkbp:notableProduct |
gptkb:Argus_II_Retinal_Prosthesis_System
gptkb:Orion_Visual_Cortical_Prosthesis_System |
| gptkbp:Orion_system_target |
cortical blindness
|
| gptkbp:publiclyTraded |
yes
|
| gptkbp:stockSymbol |
gptkb:EYES
|
| gptkbp:website |
https://secondsight.com/
|
| gptkbp:bfsParent |
gptkb:Alfred_E._Mann
|
| gptkbp:bfsLayer |
5
|